Free shipping on all orders over $ 500

SBI-0640756

Cat. No. M9260

All AbMole products are for research use only, cannot be used for human consumption.

SBI-0640756 Structure
Synonym:

SBI-756

Size Price Availability Quantity
5mg USD 215 In stock
10mg USD 300 In stock
25mg USD 640 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

SBI-0640756 is a first-in-class inhibitor that targets eIF4G1 and disrupts the eIF4F complex. SBI-0640756 impaired the eIF4F complex assembly independently of mTOR and attenuated growth of BRAF-resistant and BRAF-independent melanomas. SBI-0640756 (SBI-756) inhibits the growth of NRAS, BRAF, and NF1-mutant melanomas in vitro.

In vivo, SBI-0640756 (SBI-756) delays the onset and reduces the incidence of Nras/Ink4a melanomas.

Protocol (for reference only)
Cell Experiment
Cell lines Melanoma lines
Preparation method Melanoma lines are plated (triplicates 384-well plates; 1,500 cells per well) and cell viability is assessed 48 hours after treatment with indicated compounds. Growth inhibition is calculated as percentage of DMSO-treated controls and is plotted against the log drug concentration.
Concentrations 1, 2, 5 μmol/L
Incubation time 48 h
Animal Experiment
Animal models
Formulation
Dosages
Administration
Chemical Information
Molecular Weight 404.82
Formula C23H14ClFN2O2
CAS Number 1821280-29-8
Form Solid
Solubility (25°C) DMSO: ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Feng Y, et al. Cancer Res. SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex.

Related Eukaryotic Initiation Factor Products
4E1RCat

4E1RCat is a dual inhibitor of eIF4E:eIF4G and eIF4E:4E-BP1 interaction, and inhibits the binding of eIF4G to eIF4E with IC50 of 3.2 μM.

4EGI-1

4EGI-1 is a competitive eIF4E/eIF4G interaction inhibitor by binding to eIF4E with KD of 25 μM.

Zotatifin

Zotatifin is a first-in-class, sequentially selective inhibitor of RNA helicase eIF4A1.

GCN2iB

GCN2iB is an ATP-competitive inhibitor of a serine/threonine-protein kinase general control nonderepressible 2 (GCN2), with an IC50 of 2.4 nM.

GCN2-IN-1

GCN2-IN-1 (A-92) is a potent general control nonderepressible 2 kinase (GCN2) inhibitor with an IC50 of <0.3 μM in the enzyme assay and an IC50 of 0.3-3 μM in the cell assay.

  Catalog
Abmole Inhibitor Catalog




Keywords: SBI-0640756, SBI-756 supplier, Eukaryotic Initiation Factor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.